Новые правила оплаты регистрации лекарственных средств и медицинских изделий в Узбекистане
December 03, 2024
September 25, 2024
Dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI Milan in 8-10 October 2024
Inpharmatis Team is pleased to announce that dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI 2024 from October 8 to 10 at Milan in Italy.
We look forward to meeting you and exploring new opportunities for collaboration together with our expertise in the following areas:
- Regulatory Affairs & Market Access
- API GMP audits, EU and EAEU GMP inspection support
- Pharmacovigilance services in the CIS regions
Contact us to book a time slot for a meeting: sales@inpharmatis.com
Looking forward to meeting you in Milan!
New Payment Rules for Medicines and Medical Device Registration in Uzbekistan
December 03, 2024
Inpharmatis открыла юридическое лицо в Узбекистане
November 28, 2024
Inpharmatis Opens an LLC Legal Entity in Uzbekistan
November 28, 2024
Полина Домбуре, генеральный директор Inpharmatis Group, выступит спикером на вебинаре, организованном TOPRA
October 16, 2024
Dr. Polina Dombure to Speak at TOPRA Webinar "Navigating Regulatory Changes in Moldova and Ukraine"
October 16, 2024
Полина Домбуре, генеральный директор Inpharmatis Group, примет участие в CPHI Milan 8-10 октября 2024
September 25, 2024
Dr. Polina Dombure, CEO of Inpharmatis Group, will be attending CPHI Milan in 8-10 October 2024
September 25, 2024
Полина Домбуре, генеральный директор Inpharmatis Group, выступит спикером на вебинаре, организованном TOPRA
September 13, 2024
Dr. Polina Dombure to Speak at TOPRA Webinar on “Overcoming Regulatory Challenges in Azerbaijan and Georgia”
September 13, 2024